Moderna’s Cancer-Vaccine Leak Spurred Panic Selling as Wall Street Wanted a Cure

Moderna and Merck’s cancer vaccine reduced the risk of melanoma recurrence or death by 42%, but investors questioned its potential across other cancers.

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.barrons.com)